Services

From Discovery to Clinical Translation

ZRO supports the full development path for PET tracers, from preclinical evaluation to first-in-human imaging. We design and execute studies that measure tracer behavior, brain uptake, and target engagement, transforming early discovery data into evidence that drives confident development decisions.

Expertise in Novel PET Tracers

Our team has extensive experience with amyloid and tau PET and applies the same scientific rigor to next-generation tracers targeting key mechanisms in neurodegenerative disease.

Through radiochemistry partnerships, harmonized protocols, and validated analysis methods, we generate reproducible, quantitative data that accelerate tracer validation and clinical translation.

Why Sponsors Choose ZRO

We turn complex imaging into clear decisions. From early characterization to clinical translation, we move fast, stay precise, and deliver results that strengthen interpretation and support confident go/no-go calls.

Key Capabilities

• Early-phase study design for tracer characterization
• Quantitative analysis of tracer uptake, kinetics, and target engagement
• Standardized imaging and analysis methods across study sites
• Data packages to inform INDs, regulatory discussions, and scientific publication